Reorganizing the approach to diabetes through the application of registries

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus

Lisa A. Wozniak, Allison Soprovich, Jeffrey Johnson, Dean T. Eurich

BMC Health Services Research2021-05-036 citations

Working towards a better understanding of type 2 diabetes care organization with First Nations communities: a qualitative assessment.

Wozniak LA, Johnson JA, Eurich DT.

2020-02-044 citations

10.1186/s13690-020-0391-8

Addressing the gaps in diabetes care in first nations communities with the reorganizing the approach to diabetes through the application of registries (RADAR): the project protocol.

Eurich DT, Majumdar SR, Wozniak LA, Soprovich A, Meneen K, Johnson JA, Samanani S.

2017-02-0610 citations

10.1186/s12913-017-2049-y

Interventions

This is a modified stepped-wedge controlled implementation trial. It's a cross-over design, whereby each community serves as its own control before 'switching' to the intervention at different time po

and, a centralized care coordinator (CC). The CARE platform was designed by OKAKI Health Intelligence Inc. to meet the specific requirements of nursing-driven health programs currently being delivered

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients >18 years of age diagnosed with type 2 diabetes 2. Recently (within last 1-2 years) received care from the First Nations health facility 3. Provided verbal consent for First Nations health care workers to manage their diabetes

Exclusion criteria

Exclusion criteria: 1. Patients with type 1 diabetes 2. Patients <18 years of age 3. Those who are subsequently discovered not to have type 2 diabetes (and were not initially in the baseline period) 4. Those refusing care within the First Nations health facility; patients with type 2 diabetes identified after the conclusion of the baseline phase of the project

Design outcomes

Primary

Measure	Time frame
1. A1c 2. Blood pressure 3. Cholesterol Data collected for regular clinical care is used to assess the primary and secondary outcomes. There is no additional data collected from patients specific to the RADAR study. It may be considered a type of chart review. Timepoints: baseline, end of Intervention (minimum 1 year, depending on the community).	—

Secondary

Measure	Time frame
1. The proportion of clinical measures and tasks completed in accordance with Canadian Diabetes Association Clinical Practice guidelines (e.g., A1c, BP, cholesterol, foot and eye examination, receipt of vaccinations, smoking cessation counseling) 2. The number of patients registered in CARE 3. The proportion of patients linked to a health services provider Data collected for regular clinical care is used to assess the primary and secondary outcomes. There is no additional data collected from patients specific to the RADAR study. It may be considered a type of chart review. Timepoints: baseline, end of Intervention (minimum 1 year, depending on the community).	—

Measure

Time frame

1. The proportion of clinical measures and tasks completed in accordance with Canadian Diabetes Association Clinical Practice guidelines (e.g., A1c, BP, cholesterol, foot and eye examination, receipt of vaccinations, smoking cessation counseling) 2. The number of patients registered in CARE 3. The proportion of patients linked to a health services provider Data collected for regular clinical care is used to assess the primary and secondary outcomes. There is no additional data collected from patients specific to the RADAR study. It may be considered a type of chart review. Timepoints: baseline, end of Intervention (minimum 1 year, depending on the community).

—

Countries

Canada

Outcome results

None listed